SINGULAIR - 0006-3841-14 - (montelukast sodium)

Alphabetical Index


Drug Information of SINGULAIR

Product NDC: 0006-3841
Proprietary Name: SINGULAIR
Non Proprietary Name: montelukast sodium
Active Ingredient(s): 4    mg/1 & nbsp;   montelukast sodium
Administration Route(s): ORAL
Dosage Form(s): GRANULE
Coding System: National Drug Codes(NDC)

Labeler Information of SINGULAIR

Product NDC: 0006-3841
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021409
Marketing Category: NDA
Start Marketing Date: 20020726

Package Information of SINGULAIR

Package NDC: 0006-3841-14
Package Description: 4 PACKET in 1 CARTON (0006-3841-14) > 1 GRANULE in 1 PACKET

NDC Information of SINGULAIR

NDC Code 0006-3841-14
Proprietary Name SINGULAIR
Package Description 4 PACKET in 1 CARTON (0006-3841-14) > 1 GRANULE in 1 PACKET
Product NDC 0006-3841
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name montelukast sodium
Dosage Form Name GRANULE
Route Name ORAL
Start Marketing Date 20020726
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name MONTELUKAST SODIUM
Strength Number 4
Strength Unit mg/1
Pharmaceutical Classes Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]

Complete Information of SINGULAIR


General Information